Co-Diagnostics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $161 | $252 | $3,555 | $2,457 |
Gross Profit | -389 | -312 | 274 | 2,201 |
EBITDA | -9,837 | -10,143 | -11,512 | -9,202 |
EBIT | -10,175 | -10,474 | -11,825 | -9,499 |
Net Income | -7,599 | -9,312 | -14,676 | -5,982 |
Net Change In Cash | 161 | 252 | 3,555 | 2,457 |
Free Cash Flow | -5,302 | -8,892 | -5,243 | -6,831 |
Cash | 13,858 | 23,099 | 14,916 | 10,239 |
Basic Shares | 30,124 | 29,842 | 31,259 | 29,361 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $991 | $34,218 | $97,885 | $74,552 |
Gross Profit | -4,423 | 28,737 | 86,310 | 57,961 |
EBITDA | -47,296 | -2,681 | 46,444 | 42,707 |
EBIT | -48,526 | -3,994 | 46,109 | 42,569 |
Net Income | -35,332 | -14,238 | 36,658 | 42,478 |
Net Change In Cash | 991 | 34,218 | 97,885 | 74,552 |
Cost of Revenue | -65,633 | 45,630 | 42,083 | |
Free Cash Flow | -23,447 | 5,141 | 40,411 | 27,390 |
Cash | 14,916 | 22,973 | 88,607 | 42,976 |
Basic Shares | 29,346 | 31,479 | 29,903 | 28,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.14 |
2024-03-31 | -$0.31 |
2023-12-31 | -$0.50 |
2023-09-30 | -$0.20 |
